Medical Cannabis for Multiple Sclerosis UK

Can Medical Cannabis Help Multiple Sclerosis?

Multiple sclerosis affects over 130,000 people in the UK. For many MS patients, conventional treatments manage symptoms only partially. Medical cannabis has emerged as one of the most clinically supported options for treatment-resistant MS symptoms.

Sativex is licensed by the MHRA specifically for MS-related spasticity, making MS one of the few conditions with an officially approved cannabis medicine in the UK.

Which MS Symptoms Does Medical Cannabis Treat?

• Spasticity: Multiple randomised controlled trials show cannabis significantly reduces spasticity scores.
• Neuropathic pain: The burning, stabbing nerve pain of MS responds well to cannabinoids, especially THC and CBD combinations.
• Sleep disruption: Over 70% of MS patients report sleep problems. Cannabis medicines substantially improve sleep quality.
• Bladder dysfunction: Urinary urgency and frequency show meaningful improvement in several trials.

The Evidence

The CAMS trial followed 630 MS patients over 12 months, showing statistically significant improvements in spasticity. A 2022 systematic review of 17 trials involving 3,000+ MS patients confirmed cannabinoid-based medicines produce clinically meaningful reductions in spasticity and pain.

How to Get a Prescription for MS

1. Book an initial consultation at a specialist cannabis clinic
2. Provide your MS diagnosis documentation
3. Discuss symptoms and previous treatments
4. Receive a prescription dispensed by a licensed pharmacy

Monthly costs: £150-350. Compare prices on LeafMe to save £30-80 per month.